Table 2.
Status | Percentage |
---|---|
Overall complete ablation | 26/26 (100%) |
Local recurrence at ablated site | 2/26 (7.69%) |
New intrahepatic recurrence | 7/26 (26.9%) |
Death | 1/26 (3.85%) |
1-year tumor-free survival | 17/26 (67.4%) |
2-year tumor-free survival | 12/26 (46.1) |
3-year tumor-free survival | 9/26 (39.3%) |